These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 31254522

  • 1. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
    Dessie SG, Von Bargen E, Hacker MR, Haviland MJ, Elkadry E.
    Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
    Adelowo A, Hacker MR, Shapiro A, Modest AM, Elkadry E.
    Female Pelvic Med Reconstr Surg; 2013 Nov; 19(5):288-92. PubMed ID: 23982578
    [Abstract] [Full Text] [Related]

  • 3. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
    Morrissey D, El-Khawand D, Ginzburg N, Wehbe S, O'Hare P, Whitmore K.
    Female Pelvic Med Reconstr Surg; 2015 Nov; 21(5):277-82. PubMed ID: 25900057
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kwanchuay P, Petchnumsin T, Yiemsiri P, Pasuk N, Srikanok W, Hathaiareerug C.
    J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
    [Abstract] [Full Text] [Related]

  • 5. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group.
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [Abstract] [Full Text] [Related]

  • 6. OnabotulinumtoxinA Injections for the Treatment of Myofascial Pelvic Pain: 12-Year Experience at a Tertiary Care Academic Center.
    Lewis GK, Carrubba AR, Stanton AP, Craver EC, Li Z, Chen AH.
    Gynecol Obstet Invest; 2023 Nov; 88(1):37-46. PubMed ID: 36577396
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study.
    Levesque A, Ploteau S, Michel F, Siproudhis L, Bautrant E, Eggermont J, Rabischong B, Volteau C, Perrouin-Verbe MA, Labat JJ.
    Ann Phys Rehabil Med; 2021 Jan; 64(1):101354. PubMed ID: 31981833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A.
    Ferrante FM, Bearn L, Rothrock R, King L.
    Anesthesiology; 2005 Aug; 103(2):377-83. PubMed ID: 16052120
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Concurrent Retropubic Midurethral Sling and OnabotulinumtoxinA for Mixed Urinary Incontinence: A Randomized Controlled Trial.
    Komar A, Bretschneider CE, Mueller MG, Lewicky-Gaupp C, Collins S, Geynisman-Tan J, Tavathia M, Kenton K.
    Obstet Gynecol; 2021 Jan 01; 137(1):12-20. PubMed ID: 33278293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA, Costa D, Morgado A, Pereira P, Charrua A, Silva J, Cruz F.
    J Urol; 2018 Apr 01; 199(4):998-1003. PubMed ID: 29031769
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY, Wang D.
    Curr Pain Headache Rep; 2014 Jan 01; 18(1):386. PubMed ID: 24338700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and Efficacy of PrabotulinumtoxinA (Nabota®) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study.
    Kim DY, Kim JM.
    Toxins (Basel); 2018 Sep 03; 10(9):. PubMed ID: 30177597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.